Scotland · NHS Scotland MSAN
Rifadin® (rifampicin) 100mg/5ml oral suspension
MSAN(2020)116 · Level 2 · issued 29 Dec 2020
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 2. Until w/c 18 January 2021, supplies will only remain available to primary care (see | Available | w/c 18 January 2021 |
| 4. Rifampicin 150mg and 300mg capsules remain available. | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.